Veronique Bouchet

Veronique Bouchet has a diverse work experience in the medical and biotechnology industries. Veronique started their career as the Director of Corporate Business Development at AstraZeneca from an unknown start date to 2006. Veronique then held positions at AstraZeneca as the Head of Venture Strategy from 2006 to 2008 and as the Director of Corporate Strategy and Head of VC Relations from 2008 to 2011.

In 2011, Veronique founded Novudel Associates, a consultancy that supports venture capital, pharmaceutical, biotechnology, and digital health companies in developing strategic plans for financing and business development activities.

Veronique later joined PrecisionLife in 2017 as the Chief Medical Officer. PrecisionLife is an AI-enabled drug precision medicine company that specializes in generating disease insights, identifying biomarkers, and building combinatorial risk scores for disease risk, progression, and therapy response.

Veronique also served as the Non-Executive Director at Stevenage Bioscience Catalyst from 2012 to 2022. Stevenage Bioscience Catalyst is the UK's first open innovation bioscience campus, providing small biotech and life sciences companies with access to expertise and scientific facilities.

Additionally, Veronique held roles as the Senior Independent Director at International Biotechnology Trust from 2009 to 2021, and as a member of the Scientific Committee and Trustee at Breast Cancer Now from 2011 to 2019. Veronique also served as a guest member on the TSB Biomedical Catalyst Major Awards Committee from 2014 to 2015, where they assessed and approved late-stage applications for non-dilutive grant funding to support medical research and innovation.

Veronique's involvement in the academic field includes being a member of the QMUL School of Business and Management Advisory Board from 2014 to 2021 and serving on the Council and Finance and Investment Committee at Queen Mary University of London from 2012 to 2019.

Veronique's extensive experience and roles in various organizations demonstrate their expertise in strategy development, business development, and venture capital relations in the pharmaceutical and biotechnology industries.

Veronique Bouchet has a diverse education history. In 1977, they enrolled in St Bartholomew's Hospital Medical School, where they studied medicine. Veronique pursued this field until 1983, when they completed their MB BS degree. During their time at St Bartholomew's Hospital Medical School, Veronique also pursued an additional degree in psychology. In 1979, they started their Bsc in psychology at UCL and finished it in 1980.

Later, in 1994, Veronique attended INSEAD and obtained their MBA in Business. This brief period of education likely provided their with valuable knowledge and skills in the field. Then, in 2004, they enrolled in the Coaching Academy UK, where they pursued a Coaching Diploma from 2004 to 2006. This program probably helped their develop expertise in coaching techniques.

Finally, in 2011, Veronique attended the Institute of Directors (IoD) and successfully earned their Diploma in Company Direction with Distinction. This achievement indicates their dedication and proficiency in company direction.

Overall, Veronique Bouchet's education history consists of a solid foundation in medicine, with additional degrees in psychology, business, coaching, and company direction.